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Abstract
C28H20FN3O2S, triclinic, P1¯ (no. 2), a= 9.1325(7) Å,
b= 11.5184(9) Å, c= 11.6535(9) Å, α= 74.682(7)°,
β= 84.253(6)°, γ= 76.720(6)°, V = 1149.68(15) Å3, Z= 2,
Rgt(F)=0.0574, wRref(F2)=0.1438, T= 296(2) K.
CCDC no.: 1964866
The molecular structure is shown in the figure. Table 1
contains crystallographic data and Table 2 contains the list
of the atoms including atomic coordinates and displacement
parameters.
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Table 1: Data collection and handling.
Crystal: Yellow needle
Size: 0.27×0.16×0.10 mm
Wavelength: Mo Kα radiation (0.71073 Å)
µ: 0.18 mm−1
Diffractometer, scan mode: SuperNova, ω
θmax, completeness: 29.6°,>99%
N(hkl)measured, N(hkl)unique, Rint: 8916, 5371, 0.025
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 3323
N(param)refined: 316
Programs: CrysAlisPRO [1], SHELX [2, 3],
WinGX/ORTEP [4]
Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
C1 0.1169(3) 0.9835(2) 0.2910(2) 0.0435(5)
C2 0.1309(3) 1.1006(2) 0.3110(2) 0.0547(6)
C3 −0.1315(3) 1.1361(2) 0.3741(2) 0.0501(6)
C4 −0.1501(3) 1.0316(2) 0.3454(2) 0.0472(6)
C5 −0.0192(3) 0.9543(2) 0.3071(2) 0.0456(6)
H5 −0.028348 0.880682 0.292655 0.055*
C6 −0.2495(3) 1.2147(3) 0.4163(2) 0.0643(7)
H6 −0.233364 1.282813 0.437781 0.077*
C7 −0.3903(4) 1.1906(3) 0.4259(3) 0.0735(9)
H7 −0.470727 1.242712 0.454459 0.088*
C8 −0.4148(3) 1.0899(3) 0.3938(3) 0.0716(8)
H8 −0.511818 1.076008 0.397977 0.086*
C9 −0.2958(3) 1.0103(3) 0.3556(2) 0.0634(7)
H9 −0.312440 0.941127 0.336331 0.076*
C10 0.2511(3) 0.9040(2) 0.2520(2) 0.0447(5)
C11 0.3852(3) 0.9331(2) 0.2113(2) 0.0584(7)
H11 0.407209 1.009785 0.203622 0.070*
C12 0.3697(3) 0.7263(2) 0.2201(2) 0.0434(5)
C13 0.2927(3) 0.5250(2) 0.2330(2) 0.0438(5)
H13 0.202208 0.567602 0.188277 0.053*
C14 0.3852(3) 0.4229(2) 0.1757(2) 0.0481(6)
H14A 0.387672 0.341846 0.228688 0.058*
H14B 0.344204 0.426431 0.100930 0.058*
C15 0.5387(3) 0.4522(2) 0.15642(19) 0.0438(5)
C16 0.2500(2) 0.47624(19) 0.36272(19) 0.0408(5)
C17 0.3128(3) 0.4993(2) 0.4549(2) 0.0474(6)
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Table 2 (continued)
Atom x y z Uiso*/Ueq
H17 0.383503 0.548820 0.438136 0.057*
C18 0.2720(3) 0.4497(2) 0.5725(2) 0.0548(6)
H18 0.314053 0.465710 0.634665 0.066*
C19 0.1696(3) 0.3774(2) 0.5946(2) 0.0550(6)
C20 0.1048(3) 0.3507(2) 0.5069(2) 0.0589(7)
H20 0.035000 0.300331 0.524899 0.071*
C21 0.1464(3) 0.4010(2) 0.3908(2) 0.0528(6)
H21 0.103771 0.383927 0.329463 0.063*
C22 0.6760(3) 0.3764(2) 0.1166(2) 0.0486(6)
C23 0.8139(3) 0.4104(3) 0.1098(2) 0.0622(7)
H23 0.819715 0.480260 0.133403 0.075*
C24 0.9424(3) 0.3410(3) 0.0681(3) 0.0724(8)
H24 1.033761 0.365002 0.063679 0.087*
C25 0.9373(4) 0.2365(3) 0.0328(2) 0.0667(8)
C26 0.8015(4) 0.2030(3) 0.0418(2) 0.0683(8)
H26 0.796548 0.132282 0.019511 0.082*
C27 0.6710(3) 0.2712(2) 0.0831(2) 0.0579(7)
H27 0.580369 0.245967 0.088105 0.069*
C28 1.0790(4) 0.1634(3) −0.0156(3) 0.0968(12)
H28Aa 1.162152 0.201258 −0.014856 0.145*
H28Ba 1.099749 0.080646 0.033328 0.145*
H28Ca 1.064672 0.162218 −0.095685 0.145*
H28Da 1.055563 0.094824 −0.036619 0.145*
H28Ea 1.117966 0.215436 −0.084803 0.145*
H28Fa 1.153043 0.133863 0.044209 0.145*
N1 0.2415(2) 0.78356(16) 0.25686(16) 0.0446(5)
N2 0.3994(2) 0.60672(17) 0.21527(17) 0.0482(5)
N3 0.5421(2) 0.55653(17) 0.17574(16) 0.0468(5)
O1 0.00688(19) 1.16673(15) 0.35960(17) 0.0607(5)
O2 0.2400(2) 1.14491(18) 0.2892(2) 0.0850(7)
S1 0.50975(8) 0.81025(6) 0.17575(7) 0.0622(2)
F1 0.1273(2) 0.33016(17) 0.70997(13) 0.0830(5)
aOccupancy: 0.5.
Source of material
The title compound was synthesized from the reac-
tion of equimolar quantities of 5-(4-fluorophenyl)-3-(4-
methylphenyl)-4,5-dihydro-1H -pyrazole-1-carbothioamide
and 3-(2-bromoacetyl)-2H-chromen-2-one in anhydrous
ethanol under reflux for 2 h. The crude product obtained
was collected by filtration, washed with ethanol and recrys-
tallized from dimethylformamide to give colourless crystals
(88%).
Experimental details
The electron density for the methyl group hydrogens was dis-
tributed over several positions and so these hydrogens were
modeled in six positions of equal (0.5) occupancy around the
methyl C atom. All hydrogen atoms were placed in calculated
positions and refined using a riding model. Methyl C—H
bonds were fixed at 0.96 Å, with displacement parameters 1.5
times Ueq(C). C—H distances for sp2 hybridized groups were
set to 0.93 Å and their U iso(H) set to 1.2 times the Ueq(C).
Methylene C—H bond distances were set to 0.97 Å andU iso(H)
set to 1.2 times the Ueq(C). The methine C—H bond distance
was set to 0.98 Å and U iso(H) set to 1.2 times the Ueq(C). The
high R1 value for all reflections is attributable to theweakness
of high angle data, particularly above 0.86 Å resolution.
Comment
The synthesis of novel heterocycles containing thiazolyl-
pyrazoline moieties are of interest since such compounds
show a range of biological and medicinal applications
[5–9]. In addition, coumarinyl-thiazole containing heterocy-
cles showed interesting applications [10–12]. Related struc-
tures have been reported [13, 14].
In the crystal structure, the asymmetric unit consists of
one molecule (see the figure). The molecule comprises five
ring systems, namely:A, chromenonyl (C1—C9,O1,O2);B, thia-
zolyl (C10—C12,N1,S1); C, pyrazolyl (C13—C15,N2,N3); D, tolyl
(C22—C28) and E, fluorophenyl (C16—C21,F1) groups. Rings
A to D are almost co-planar with interplanar angles A/B,
B/C,C/D of 15.50(8)°, 12.59(11)° and 7.02(13)° respectively. The
angle between C and E is 67.40(9)°.
The molecule displays an almost weak intramolecular
C—H· · ·O contact with a C· · ·O distance of 2.824(3) Å and
a C11—H11· · ·O2 angle of 117.3°. In the crystal structure, a
close intermolecular C—H· · ·N contact with a C· · ·N dis-
tance of 3.511(3) Å and C18—H18· · ·N3 angle of 163.8° is
also observed. Fluorophenyl groups of neighbouring pairs
of molecules are parallel with a ring centroid separation
of 3.84 Å. Chromenonyl groups of adjacent molecules are
also parallel with a fused-ring centroid-to-centroid distance
of 4.164 Å. Lack of strong directional interactions or steric
constraints account for the rotational disorder in the methyl
group.
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